Moxifloxacin vs. Polytrim for Conjunctivitis
- Registration Number
- NCT00581542
- Lead Sponsor
- University of Rochester
- Brief Summary
The purpose of the study is to compare the effect of Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution in treating your child's pink eye. Both these medications are approved by the Food and Drug Administration, for treatment of conjunctivitis. This study will investigate if both of the medications are equally good.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 124
- 1 - 18 years of age with presumed bacterial conjunctivitis.
- Previous antibiotics or to receive systemic antibiotic.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Moxifloxacin Opthalmic solution polytrim - Polymyxin B-trimethoprim opthalmic solution moxifloxacin -
- Primary Outcome Measures
Name Time Method Number of Participants With Normal Physical Examination of the Eye 10 days
- Secondary Outcome Measures
Name Time Method Number of Participants With a Negative Bacterial Culture 10 days Conjunctival swab specimens were inoculated onto tryptic soy agar with 5% sheep blood and GC II agar supplemented with hemoglobin and isovialex with incubation at 35 degrees C in ambient air supplemented with 5% carbon dioxide for 48 hours. S pneumoniae, H influenzai and M Catarrhalis were identified.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University of Rochester
🇺🇸Rochester, New York, United States